Author name: Leonardo Arias

Dr. Stanley Crittenden will take up the post at Cigna’s health benefits division months after his predecessor became CMO of the entire organization.

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate the natural electrical system.

The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.

Thermo Fisher plans to create a fast-growing business by integrating Clario’s data capture and management system with its existing capabilities.

The Belgian drugmaker plans to hire about 330 people at a facility that will use advanced manufacturing technologies including AI, robotics and automation to meet rising demand for key products. This will be UCB’s first biologics manufacturing facility in the U.S.

The shareholders, members of the Interfaith Center on Corporate Responsibility, have been trying to get the healthcare juggernaut to share more information about its controversial business practices for more than a year.

This year’s catalysts in the space include a near-term FDA decision on Eli Lilly’s oral challenger to the new Wegovy pill. Looking further ahead, Novo Nordisk is expecting more clinical data for next-gen weight loss asset CagriSema, which recently lost a head-to-head battle with Lilly’s Zepbound.

Looking for a biopharma job in New York? Check out the BioSpace list of 11 companies hiring life sciences professionals like you.

La biopsia líquida ha dejado de ser una promesa lejana. Hoy se abre paso en hospitales, centros de investigación y laboratorios clínicos como una herramienta de gran valor para detectar señales tempranas de cáncer a partir de una muestra de sangre. La idea es simpl …

Merck’s acquisition of Terns Pharmaceuticals follows other big-ticket purchases, including of Verona Pharma and Cidara Therapeutics, as the pharma prepares for the impending expiry of its blockbuster’s patents.